# Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

> **NCT01311778** · PHASE1 · COMPLETED · sponsor: **Hurd,Yasmin, Ph.D.** · enrollment: 18 (actual)

## Conditions studied

- Opiate Addiction

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT01311778
- **Lead sponsor:** Hurd,Yasmin, Ph.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311778, "Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01311778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*